Abstract
Dentsply Sirona will announce its first-quarter 2026 financial results on May 5, 2026 Post Market, and consensus currently points to modest year-over-year declines in revenue and adjusted EPS, with digital equipment and channel initiatives shaping the near-term performance profile.Market Forecast
Based on the latest compiled expectations, Dentsply Sirona is projected to deliver revenue of 842.59 million US dollars for the current quarter, down 1.47% year over year, adjusted EPS of 0.28 (down 3.64% year over year), and EBIT of 97.32 million US dollars (up 5.95% year over year). Forecasts for gross margin and net margin have not been provided.The company’s main business mix continues to reflect a balance between consumables and digital equipment, with recent go-to-market moves focused on accelerating technology adoption and stabilizing channel dynamics. The most promising area in the near term is Connected Technology Solutions, supported by product innovation and expanded distribution; the segment generated approximately 270.54 million US dollars last quarter, while year-over-year growth for this segment was not disclosed.
Last Quarter Review
In the previous quarter, Dentsply Sirona posted revenue of 961.00 million US dollars with a gross profit margin of 46.10%, a GAAP net loss attributable to shareholders of 146.00 million US dollars (net profit margin -15.19%), and adjusted EPS of 0.27, which increased 3.85% year over year.A key highlight was the top-line beat versus consensus, while adjusted EPS was a fractional miss, indicating the quarter’s operating leverage remained mixed despite volume growth. Within the portfolio, the revenue mix was anchored by Basic Dental Solutions at approximately 383.62 million US dollars (around 39.92% of last quarter revenue), Connected Technology Solutions at 270.54 million US dollars (around 28.15%), Orthodontics and Implants Solutions at 221.97 million US dollars (around 23.10%), and Wellspect Healthcare at 84.87 million US dollars (around 8.83%); year-over-year changes by segment were not disclosed.
Current Quarter Outlook
Main Commercial Drivers This Quarter
The primary driver this quarter is expected to be execution in digital technologies and imaging alongside stabilization in consumables demand. Consensus revenue of 842.59 million US dollars implies a modest year-on-year contraction, which, taken with the projected decline in adjusted EPS, suggests pricing, mix, or investment spending could weigh on earnings even if equipment volumes improve. The mixed setup is consistent with a post-year-end cadence where practices typically reassess capital priorities, and where sales force and distribution alignment are critical for conversion.The company’s EBIT forecast of 97.32 million US dollars, up 5.95% year over year, points to potential operating expense discipline and incremental efficiencies that partially offset the revenue headwind. This spread between top-line and operating-income expectations indicates management’s cost initiatives and portfolio focus may be gaining traction even as the sales environment remains selective. If sustained, this pattern would help rebuild earnings power without requiring outsized growth, but execution consistency remains the hinge.
Consumables should remain the bedrock, helping to smooth volatility from lumpier equipment cycles. The prior quarter’s mix tallied Basic Dental Solutions at about 383.62 million US dollars and Orthodontics and Implants Solutions at 221.97 million US dollars, together representing roughly 63% of quarterly revenue. A steady consumables baseline, combined with targeted product refreshes and clinical education, can support utilization, even if macro and patient-traffic dynamics introduce variability to the cadence of elective procedures. The reliance on these categories this quarter will be to sustain volume while the company prioritizes channel repairs and technology-led pull-through.
Most Promising Segment: Connected Technology Solutions
Connected Technology Solutions stands out this quarter due to a combination of distribution expansion and a visible innovation pipeline. Last quarter, the segment generated approximately 270.54 million US dollars, around 28.15% of total company revenue, giving it sufficient scale for operational leverage as order patterns normalize. The recent expansion of distribution coverage with Burkhart Dental Supply for the full technology portfolio, effective April, positions Dentsply Sirona to deepen penetration of CEREC systems, intraoral scanning, and imaging in key practice cohorts at the outset of the quarter.Product momentum is further underpinned by the reported FDA clearance of a dental-dedicated MRI system (developed in collaboration with Siemens Healthineers), which could expand the imaging addressable use-cases over time and catalyze cross-selling opportunities across software and hardware. While the revenue contribution from this new modality may phase in gradually, its presence strengthens the narrative for digital workflows that integrate diagnostics, restorative planning, and chairside production. This alignment of channel reach and innovation is a constructive setup for the technology suite this quarter, even as practices weigh capital budgets more carefully than in high-growth periods.
From a financial lens, consensus projects overall revenue contracting 1.47% year over year and adjusted EPS declining 3.64%. Against this backdrop, technology-led uplift will be assessed in terms of order intake, pipeline conversion rates, and the quality of bookings. The technology portfolio’s performance, if it meets or exceeds internal targets, could offset softer areas and support EBIT resilience. The investment case within the quarter will likely hinge on evidence that distribution breadth is translating into a healthier order book and a sustainable demo-to-close ratio.
Key Stock Price Drivers in the Quarter
The first clear stock driver is the revenue-to-earnings bridge. With EBIT expected to rise 5.95% year over year despite a forecast revenue decline, investors will examine gross-to-operating leverage to assess the durability of cost controls and the mix of high-margin product attachment. A stable or improved gross margin relative to last quarter’s 46.10%, if reported, would be interpreted positively, especially if driven by pricing discipline and favorable product mix rather than one-off cost items.The second driver is channel execution and order momentum in digital equipment. The expanded distribution agreement for the technology portfolio, coming at the start of April, provides a test case for coverage density, installer capacity, and post-install service quality. Any quantified updates on lead pipelines, conversion cycles, and backlog health would be taken as near-term read-throughs on Connected Technology Solutions and could influence forward-quarter expectations.
The third driver is the broader capital allocation and policy framework. An earlier sell-side note flagged the possibility of changes to the dividend and elevated investment spending as management prioritizes channel repairs and long-term growth. Should management signals reinforce a reallocation toward growth investments, the market’s response will depend on the accompanying evidence of commercial traction and operating discipline. Clarity around spending cadence and payback windows would help the market calibrate sustainable EPS power this year.
Analyst Opinions
The balance of directional views collected in recent weeks skews bullish. Notably, BofA Securities upgraded Dentsply Sirona to Buy and increased its price target to 17.00 US dollars, citing an improving setup as new leadership accelerates channel repair and enhances line of sight to more stable growth. UBS maintained a Buy rating with a 16.00 US dollars target, while Barrington Research kept an Outperform rating and raised its target to 17.00 US dollars. These calls converge on the same core thesis for the quarter: commercial execution in digital technology and distribution can provide a bridge to earnings stability as management retools commercial pathways.The bullish camp’s emphasis falls on three angles. First, revenue quality: even with a forecast top-line decline of 1.47% year over year, upgrading the mix in imaging, scanning, and chairside systems can protect margins and improve after-market consumables and software attachment. Second, operating discipline: EBIT is forecast to rise 5.95% year over year, suggesting that cost controls and portfolio focus are tracking. Third, the go-to-market recalibration: the extended partnership with Burkhart for the technology suite is seen as a practical catalyst to widen reach and tighten the demo-to-close funnel at the start of the quarter.
Bullish analysts also point to incremental, product-led catalysts that support the digital workflow narrative, including new imaging modalities with regulatory clearance that broaden diagnostic capabilities and potentially enhance case acceptance. In their view, even if large ticket decisions remain measured, the company’s alignment of channel, product, and service can translate into steadier order flow. This is why the projected decline in adjusted EPS of 3.64% year over year is not, by itself, viewed as determinative for the stock call this quarter; instead, execution signals on orders, margins, and spending cadence anchor the constructive stance.
From a quarter-specific lens, the bullish majority is looking for three validation points on May 5, 2026: evidence that distribution changes are improving funnel metrics in Connected Technology Solutions; indications that mix and pricing held the gross margin line near or above last quarter’s 46.10% despite revenue pressure; and signs that operating expense discipline supported the forecast EBIT trajectory of 97.32 million US dollars. If these elements are present alongside stable consumables trends, the group expects confidence to build around the back-half trajectory. In this framework, the path to re-rating is not predicated on outsized growth, but on consistent, demonstrable progress in digital execution and cost control.
Overall, the dominant directional view frames the current quarter as a proof point on channel and technology execution. The majority bullish stance is grounded in the expectation that targeted commercial actions and disciplined cost management can stabilize earnings power, setting up the company to navigate a modest revenue dip without derailing operating momentum. The call’s tone on distribution traction, digital order intake, and expense cadence will be the details this group is most focused on when the results are released Post Market on May 5, 2026.
Comments